Bayer Cropscience DuPont analysis

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.81×0.80×0.79×—
1.10×1.17×1.07×—
13.7%11.0%17.2%—
1.04×1.11×1.10×—
1.92×1.84×1.61×1.73×
24.3%21.2%25.8%—
23.7%19.9%26.6%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,375.00

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×—0.790.800.81
Interest Burden (Pretax/EBIT) ×—1.071.171.10
EBIT Margin %—17.2411.0513.74
Asset Turnover ×—1.101.111.04
Financial Leverage (Assets/Equity) ×1.731.611.841.92
ROE (5-step product, year-end total equity) %—25.7521.2024.27
ROE (owners' profit / average owners' equity) %—26.6319.9323.70
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.